跳至主要内容
临床试验/IRCT20210206050268N1
IRCT20210206050268N1招募中3 期

Evaluation and comparison of the effect of premedication (Methylprednisolone and Naproxen) with placebo in controlling acute complications of IVIG injection in patients with a diagnosis of neurological disease

Esfahan University of Medical Sciences0 个研究点目标入组 90 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • All patients with a diagnosis of neurological disease, including myasthenia gravis, Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy (CIDP), etc., who are candidates for IVIG will be included in the study.

排除标准

  • The patient's unwillingness to participate in the study

研究者

相似试验